11:23 AM
Deutsche Borse Licenses Cinnober System for Market Surveillance
Deutsche Borse has licensed Cinnober’s market surveillance technology for use at both Xetra cash market and derivatives market Eurex Exchange. The technology called Scila Surveillance will replace Deutsche Borse’s in-house solution, according to today’s release.
Deutsche Borse plans to incorporate Scila into the two exchanges, enabling it to monitor trading in batch and real-time mode simultaneously to ensure market integrity and safety.
Scila includes several customizations that are key to Deutsche Borse Group’s exchanges, according to the release. First it allows a market reply also in a graphical manner as well as a re-run of historical market situations; and secondly it enables a cross-border monitoring of Xetra and Eurex.
Exchange supervisory authorities will receive individualized reports of market activity much quicker. Scila will be able to handle more than 100,000 transactions per second, and this rate can be increased if necessary. All market data is stored and always is available so there is no need for offloading of historical data anymore.
We conducted extensive analysis of our market monitoring needs as part of our ongoing commitment to fulfill our regulatory reporting requirements. Cinnober has a stellar reputation and proven track record in providing leading technology solutions in this field. Their software Scila in particular has the ability to meet our high capacity demands and requirements," commented Michael Zollweg, head of trading surveillance Office at Deutsche Börse.
Scila Surveillance is a turnkey high-transaction solution for marketplaces, regulators and compliance departments. Launched in 2009, it has been chosen by marketplaces for equities, commodities, derivatives, FX and CFDs.
Ivy is Editor-at-Large for Advanced Trading and Wall Street & Technology. Ivy is responsible for writing in-depth feature articles, daily blogs and news articles with a focus on automated trading in the capital markets. As an industry expert, Ivy has reported on a myriad ... View Full Bio